COSPIAQ MET 12.5/500 TAB
₹416.00
COSPIAQ MET 12.5/500 TAB is a combination oral medication containing Glimepiride 12.5 mg and Metformin Hydrochloride 500 mg. It is used to improve blood sugar control in patients with type 2 diabetes mellitus by stimulating insulin release and decreasing glucose production in the liver.
Description
COSPIAQ MET 12.5/500 TAB combines two effective antidiabetic agents: Glimepiride 12.5 mg, a sulfonylurea that stimulates pancreatic beta cells to increase insulin secretion, and Metformin Hydrochloride 500 mg, a biguanide that decreases hepatic glucose production and improves insulin sensitivity.
This dual-action tablet is prescribed for the management of type 2 diabetes mellitus when diet, exercise, and single-drug therapy are insufficient to control blood glucose levels. By combining these two mechanisms, COSPIAQ MET 12.5/500 TAB helps achieve better glycemic control and reduces the risk of diabetes-related complications.
The medication is typically taken once or twice daily with meals to minimize gastrointestinal side effects. Regular blood glucose monitoring is advised during treatment.
Potential side effects may include hypoglycemia (low blood sugar), gastrointestinal discomfort, weight gain, and rarely lactic acidosis. It is important to use COSPIAQ MET under medical supervision and inform the doctor of any existing medical conditions, especially kidney or liver issues.
Reviews
There are no reviews yet.